Regulon

Regulon: R-1317

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
72.82231115Pr-137Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
5355 ENSG00000102007 PLP2 Q04941
54793 ENSG00000104756 KCTD9 Q7L273
301 ENSG00000135046 ANXA1 P04083
8915 ENSG00000142867 BCL10 O95999
5271 ENSG00000166401 SERPINB8 A0A024R2B1
84617 ENSG00000176014 TUBB6 Q9BUF5
9554 ENSG00000265808 SEC22B O75396

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
ERIBULIN MESYLATETUBB1Small moleculeINHIBITORTubulin inhibitor40
SAGOPILONETUBB1Small moleculeSTABILISERTubulin stabiliser22
AGS-16C3FTUBB1UnknownDISRUPTING AGENTTubulin disrupting agent20
TELISOTUZUMAB VEDOTINMETAntibodyBINDING AGENTHepatocyte growth factor receptor binding agent30
DOCETAXELTUBB1Small moleculeINHIBITORTubulin inhibitor40
FOSBRETABULIN DISODIUMTUBB1Small moleculeINHIBITORTubulin inhibitor20
VINCRISTINETUBB1Small moleculeINHIBITORTubulin inhibitor43
VINFLUNINETUBB1Small moleculeINHIBITORTubulin inhibitor40
LEXIBULINTUBB1Small moleculeINHIBITORTubulin inhibitor21
VINCRISTINE SULFATETUBB1Small moleculeINHIBITORTubulin inhibitor43
TRASTUZUMAB EMTANSINEERBB2AntibodyINHIBITORTubulin inhibitor40
ENFORTUMAB VEDOTINTUBB1AntibodyBINDING AGENTNectin-4 binding agent40
VINORELBINE TARTRATETUBB1Small moleculeINHIBITORTubulin inhibitor40
LIFASTUZUMAB VEDOTINTUBB1AntibodyBINDING AGENTSodium-dependent phosphate transport protein 2B binding agent20
KOS-1584TUBB1Small moleculeSTABILISERTubulin stabiliser20
PRALUZATAMAB RAVTANSINEALCAMAntibodyINHIBITORTubulin inhibitor20
LADIRATUZUMAB VEDOTINTUBB1AntibodyINHIBITORTubulin inhibitor20
PACLITAXELTUBB1Small moleculeINHIBITORTubulin inhibitor41
CROLIBULINTUBB1Small moleculeINHIBITORTubulin inhibitor10
PACLITAXEL POLIGLUMEXTUBB1Small moleculeSTABILISERTubulin stabiliser30
PATUPILONETUBB1Small moleculeSTABILISERTubulin stabiliser31
ASG-5METUBB1AntibodyINHIBITORTubulin inhibitor10
ANG1005LRP1ProteinBINDING AGENTProlow-density lipoprotein receptor-related protein 1 binding agent32
PINATUZUMAB VEDOTINTUBB1AntibodyINHIBITORTubulin inhibitor10
VERUBULINTUBB1Small moleculeDISRUPTING AGENTTubulin disrupting agent22
VINBLASTINE SULFATETUBB1Small moleculeINHIBITORTubulin inhibitor40
VINORELBINETUBB1Small moleculeINHIBITORTubulin inhibitor42
DAVUNETIDETUBB1ProteinSTABILISERTubulin stabiliser20
BELANTAMAB MAFODOTINTUBB1AntibodyBINDING AGENTTumor necrosis factor receptor superfamily member 17 binding agent40
FOSBRETABULINTUBB1Small moleculeDISRUPTING AGENTTubulin disrupting agent30
ABT-751TUBB1Small moleculeINHIBITORTubulin beta inhibitor20
MIRVETUXIMAB SORAVTANSINEFOLR1AntibodyINHIBITORTubulin inhibitor30
IXABEPILONETUBB1Small moleculeINHIBITORTubulin inhibitor41
POLATUZUMAB VEDOTINTUBB1AntibodyBINDING AGENTB-cell antigen receptor complex-associated protein beta chain binding agent40
T-900607TUBB1Small moleculeDISRUPTING AGENTTubulin disrupting agent20
APRUTUMAB IXADOTINTUBB1AntibodyBINDING AGENTFibroblast growth factor receptor 2 binding agent10
PLINABULINTUBB1Small moleculeINHIBITORTubulin inhibitor30
TISOTUMAB VEDOTINF3AntibodyBINDING AGENTCoagulation factor III binding agent40
DOLASTATIN-10TUBB1Small moleculeINHIBITORTubulin inhibitor20
FOSBRETABULIN TROMETHAMINETUBB1Small moleculeDISRUPTING AGENTTubulin disrupting agent20
SAR-408701TUBB1UnknownBINDING AGENTCarcinoembryonic antigen-related cell adhesion molecule 5 binding agent30
CABAZITAXELTUBB1Small moleculeINHIBITORTubulin inhibitor42
PACLITAXEL DOCOSAHEXAENOIC ACIDTUBB1Small moleculeSTABILISERTubulin stabiliser30
ERIBULINTUBB1Small moleculeINHIBITORTubulin inhibitor40
BMS-275183TUBB1Small moleculeSTABILISERTubulin stabiliser20
INDUSATUMAB VEDOTINTUBB1AntibodyBINDING AGENTHeat-stable enterotoxin receptor binding agent20
GLEMBATUMUMAB VEDOTINTUBB1AntibodyBINDING AGENTTransmembrane glycoprotein NMB binding agent20
COLCHICINETUBB1Small moleculeINHIBITORTubulin inhibitor40
VANDORTUZUMAB VEDOTINSTEAP1AntibodyINHIBITORTubulin inhibitor10
VINBLASTINETUBB1Small moleculeINHIBITORTubulin inhibitor40
BRENTUXIMAB VEDOTINTNFRSF8AntibodyINHIBITORTubulin inhibitor40
EPOTHILONE DTUBB1Small moleculeSTABILISERTubulin stabiliser20
SOFITUZUMAB VEDOTINTUBB1AntibodyBINDING AGENTMucin-16 binding agent10
INDIBULINTUBB1Small moleculeINHIBITORTubulin inhibitor10
AZINTUXIZUMAB VEDOTINTUBB1AntibodyINHIBITORTubulin inhibitor10
LAROTAXELTUBB1Small moleculeSTABILISERTubulin stabiliser30
RG-7841TUBB1UnknownINHIBITORTubulin inhibitor10
LORVOTUZUMAB MERTANSINENCAM1AntibodyINHIBITORTubulin inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1317

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-00717HMCN1up-regulatesCEBPBactivatesR-13172311Drugs (58)
CMF-04327RBPJLup-regulatesCEBPBactivatesR-13172311Drugs (58)
CMF-07113ATRXdown-regulatesCEBPBactivatesR-13172315Drugs (58)
CMF-09239TANC2up-regulatesCEBPBactivatesR-1317237Drugs (58)
CMF-11630CHSY3down-regulatesCEBPBactivatesR-1317231Drugs (58)
CMF-12679WDFY3up-regulatesCEBPBactivatesR-1317234Drugs (58)
CMF-15748FN1up-regulatesCEBPBactivatesR-1317233Drugs (58)
CMF-16627APOBup-regulatesCEBPBactivatesR-1317232Drugs (58)
CMF-21090KRTAP4-7up-regulatesCEBPBactivatesR-1317239Drugs (58)
CMF-21423GRIK3up-regulatesCEBPBactivatesR-1317237Drugs (58)
CMF-21717MUC17up-regulatesCEBPBactivatesR-1317238Drugs (58)
CMF-22897IDH1down-regulatesCEBPBactivatesR-13172317Drugs (58)
CMF-23282RNF17up-regulatesCEBPBactivatesR-1317236Drugs (58)
CMF-27653ANKRD36up-regulatesCEBPBactivatesR-1317236Drugs (58)
CMF-30246SCN7Aup-regulatesCEBPBactivatesR-1317232Drugs (58)